David S Wilkinson
David S Wilkinson
Verified email at mcmaster.ca
Cited by
Cited by
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
JAR Nicoll, D Wilkinson, C Holmes, P Steart, H Markham, RO Weller
Nature medicine 9 (4), 448-452, 2003
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
C Holmes, D Boche, D Wilkinson, G Yadegarfar, V Hopkins, A Bayer, ...
The Lancet 372 (9634), 216-223, 2008
Donepezil in vascular dementia: a randomized, placebo-controlled study
D Wilkinson, R Doody, R Helme, K Taubman, J Mintzer, A Kertesz, ...
Neurology 61 (4), 479-486, 2003
Pressure sintering by power law creep
DS Wilkinson, MF Ashby
Acta Metallurgica 23 (11), 1277-1285, 1975
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer, R Bullock, RW Jones, D Wilkinson, KR Paterson, L Jenkins, ...
Neurology 64 (1), 94-101, 2005
Threshold stresses for dislocation climb over hard particles: The effect of an attractive interaction
E Arzt, DS Wilkinson
Acta Metallurgica 34 (10), 1893-1898, 1986
The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease
C Holmes, D Wilkinson, C Dean, S Vethanayagam, S Olivieri, A Langley, ...
Neurology 63 (2), 214-219, 2004
Digital image correlation studies for microscopic strain distribution and damage in dual phase steels
J Kang, Y Ososkov, JD Embury, DS Wilkinson
Scripta Materialia 56 (11), 999-1002, 2007
Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial
P Scheltens, PJGH Kamphuis, FRJ Verhey, MGMO Rikkert, RJ Wurtman, ...
Alzheimer's & Dementia 6 (1), 1-10. e1, 2010
Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain
D Boche, E Zotova, RO Weller, S Love, JW Neal, RM Pickering, ...
Brain 131 (12), 3299-3310, 2008
Aβ Species Removal After Aβ42 Immunization
JAR Nicoll, E Barton, D Boche, JW Neal, I Ferrer, P Thompson, ...
Journal of Neuropathology & Experimental Neurology 65 (11), 1040-1048, 2006
Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study
C Holmes, V Hopkins, C Hensford, V MacLaughlin, D Wilkinson, ...
International journal of geriatric psychiatry 17 (4), 305-308, 2002
Effect of martensite distribution on damage behaviour in DP600 dual phase steels
G Avramovic-Cingara, Y Ososkov, MK Jain, DS Wilkinson
Materials Science and Engineering: A 516 (1-2), 7-16, 2009
Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial
K Rockwood, J Mintzer, L Truyen, T Wessel, D Wilkinson
Journal of Neurology, Neurosurgery & Psychiatry 71 (5), 589-595, 2001
Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease
D Wilkinson, J Murray, Galantamine Research Group
International journal of geriatric psychiatry 16 (9), 852-857, 2001
The Portevin–Le Chatelier (PLC) effect and shear band formation in an AA5754 alloy
H Halim, DS Wilkinson, M Niewczas
Acta Materialia 55 (12), 4151-4160, 2007
Plastic flow and fracture of a particulate metal matrix composite
MT Kiser, FW Zok, DS Wilkinson
Acta materialia 44 (9), 3465-3476, 1996
On the mechanism of strain-enhanced grain growth during superplastic deformation
DS Wilkinson, CH Caceres
Acta Metallurgica 32 (9), 1335-1345, 1984
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial
IG McKeith, JB Grace, Z Walker, EJ Byrne, D Wilkinson, T Stevens, ...
International Journal of Geriatric Psychiatry 15 (5), 387-392, 2000
The meaning and determinants of skills shortages
F Green, S Machin, D Wilkinson
Oxford Bulletin of Economics and Statistics 60 (2), 165-187, 1998
The system can't perform the operation now. Try again later.
Articles 1–20